Last $32.50 USD
Change Today +0.06 / 0.18%
Volume 108.6K
GHDX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for genomic health inc (GHDX)

Year over year, Genomic Health Inc. has seen their bottom line shrink from a gain of $8.2M USD to a loss of $12.8M USD despite an increase in revenues from $235.2M USD to $261.6M USD. An increase in the percentage of sales devoted to cost of goods sold from 16.55% to 20.92% was a key component in the falling bottom line in the face of rising revenues.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Reclassified
Dec 31
2011
Restated
Dec 31
2012
Dec 31
2013
4 Year
Trend
Revenues178.1206.1235.2261.6
TOTAL REVENUES178.1206.1235.2261.6
Cost of Goods Sold36.937.538.954.7
GROSS PROFIT141.2168.6196.2206.9
Selling General & Admin Expenses, Total106.3124.2140.6165.0
R&D Expenses31.037.047.253.7
OTHER OPERATING EXPENSES, TOTAL137.3161.1187.8218.7
OPERATING INCOME3.97.58.4-11.8
Interest and Investment Income0.20.20.30.2
NET INTEREST EXPENSE0.20.20.30.2
Income (Loss) on Equity Investments---0.2-0.1--
Currency Exchange Gains (Loss)0.00.00.0-0.2
Other Non-Operating Income (Expenses)0.0------
EBT, EXCLUDING UNUSUAL ITEMS4.17.58.6-11.8
Gain (Loss) on Sale of Investments-------0.6
Gain (Loss) on Sale of Assets0.00.00.1--
Other Unusual Items, Total--0.8----
Legal Settlements--0.8----
EBT, INCLUDING UNUSUAL ITEMS4.28.38.7-12.4
Income Tax Expense-0.10.40.40.3
Earnings from Continuing Operations4.37.88.2-12.8
NET INCOME4.37.88.2-12.8
NET INCOME TO COMMON INCLUDING EXTRA ITEMS4.37.88.2-12.8
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS4.37.88.2-12.8
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GHDX:US $32.50 USD +0.06

GHDX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cancer Genetics Inc $7.17 USD +0.05
Foundation Medicine Inc $23.96 USD -0.03
NanoString Technologies Inc $14.48 USD +0.55
NeoGenomics Inc $4.15 USD +0.12
Veracyte Inc $9.27 USD +1.03
View Industry Companies
 

Industry Analysis

GHDX

Industry Average

Valuation GHDX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.7x
Price/Book 7.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENOMIC HEALTH INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.